Risk of hypertension and reduced kidney function after acute gastroenteritis from bacteria-contaminated drinking water

CMAJ. Canadian Medical Association Journal

Volumn 173, Issue 3, 2005, Pages 261-266

  Garg, Amit X ^a,c,e   Moist, Louise ^a   Matsell, Douglas ^b   Thiessen Philbrook, Heather R ^a   Haynes, R Brian ^c   Suri, Rita S ^a   Salvador, Marina ^a   Ray, Joel ^d   Clark, William F ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DRINKING WATER;

ACUTE GASTROENTERITIS; ADULT; ARTICLE; BACTERIUM CONTAMINATION; CAMPYLOBACTER; CANADA; DISEASE SEVERITY; EPIDEMIC; ESCHERICHIA COLI O157; FEMALE; FOLLOW UP; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PROTEINURIA; RISK ASSESSMENT; WATER CONTAMINATION; WATER SUPPLY;

EID: 23244455735     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.050581     Document Type: Article

References (34)

1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349:1269-76.
2. Garg AX, Suri RS, Barrowman N, Rehman F, Matsell D, Rosas-Arellano MP, et al. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 2003;290(10):1360-70.
3. Locht H, Krogfelt KA. Comparison of rheumatological and gastrointestinal symptoms after infection with Campylobacter jejuni/coli and enterotoxigenic Escherichia coli. Ann Rheum Dis 2002;61(5):448-52.
4. Hannu T, Mattila L, Rautelin H, Pelkonen P, Lahdenne P, Siitonen A et al. Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford) 2002;41(3):312-318.
5. Bremell T, Bjelle A, Svedhem A. Rheumatic symptoms following an outbreak of campylobacter enteritis: a five year follow up. Ann Rheum Dis 1991;50(12):934-8.
6. Hughes AK, Ergonul Z, Stricklett PK, Kohan DE. Molecular basis for high renal cell sensitivity to the cytotoxic effects of shigatoxin-1: upregulation of globotriaosylceramide expression. J Am Soc Nephrol 2002;13(9):2239-45.
7. Hughes AK, Stricklett PK, Kohan DE. Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells. Kidney Int 1998;54(2):426-37.
8. Van Setten PA, van Hinsbergh VW, van den Heuvel LP, van der Velden TJ, van de Kar NC, Krebbers RJ et al. Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms. J Am Soc Nephrol 1997;8(12):1877-88.
9. Garg AX, Macnab J, Clark WF, Ray JG, Marshall JK, Suri RS, et al. Long-term health sequelae following municipal water contaminated with Escherichia coli 0157 and Campylobacter species: population sampling and assessing non-participation biases. Can J Public Health 2005;96(2):125-30.
10. Garg AX, Marshall JK, Salvadori M, Thiessen HR, Macnab J, Suri RS, et al. A gradient of acute gastroenteritis to assess risk of long-term health sequelae after drinking bacteria contaminated water. A report from the Walkerton Health Study Investigators; 2005.
11. Auld H, MacIver D, Klaassen J. Heavy rainfall and waterborne disease outbreaks: the Walkerton example [review]. J Toxicol Environ Health A 2004;67 (20-22):1879-87.
12. The investigative report of the Walkerton outbreak of waterborne gastroenteritis May-June 2000. Owen Sound (ON): Bruce-Grey Owen Sound Health Unit; 2000.
13. Hrudey S. Drinking-water risk management principles for a total quality management framework. 7 Toxicol Environ Health A 2004;67(20-22):1555-66.
14. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42(6):1206-52.
15. Niskanen L, Laaksonen DE, Nyyssonen K, Punnonen K, Valkonen VP, Fuentes R, et al. Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension 2004;44(6):859-65.
16. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA 2003;290(22):2945-51.
17. Markovitz JH, Matthews KA, Kannel WB, Cobb JL, D'Agostino RB. Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension? JAMA 1993;270(20):2439-43.
18. Reacher M, McKenzie K, Lane C, Nichols T, Kedge I, Iversen A, et al. Health impacts of flooding in Lewes: a comparison of reported gastrointestinal and other illness and mental health in flooded and non-flooded households. Commun Dis Public Health 2004;7(1):39-46.
19. Zoja C, Angioletti S, Donadelli R, Zanchi C, Tomasoni S, Binda E, et al. Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1. Kidney Int 2002;62(3):846-56.
20. Schmid DI, Kohan DE. Effect of shigatoxin-1 on arachidonic acid release by human glomerular epithelial cells. Kidney Int 2001;60(3):1026-36.
21. Pijpers AH, van Setten PA, van den Heuvel LP, Assmann KJ, Dijkman HB, Pennings AH, et al. Verocytotoxin-induced apoptosis of human microvascular endothelial cells. J Am Soc Neurol 2001;12(4):767-78.
22. Kodama T, Nagayama K, Yamada K, Ohba Y, Akeda Y, Honda T. Induction of apoptosis in human renal proximal tubular epithelial cells by Escherichia coli verocytotoxin 1 in vitro. Med Microbiol Immunol (Berl) 1999;188(2):73-8.
23. Lopez EL, Contrini MM, Devoto S, de RM, Grana MG, Aversa L, et al. Incomplete hemolytic-uremic syndrome in Argentinean children with bloody diarrhea. J Pediatr 1995;127(3):364-7.
24. Mann JF, Gerstein HC, Yi QL, Franke J, Lonn EM, Hoogwerf BJ, et al. Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study. Am J Kidney Dis 2003;42(5):936-42.
25. Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Hiev IP, Brusegan V, et al. Preventing microalbuminuria in type 2 diabetes. N Engl J Med 2004;351(19):1941-51.
26. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998;339(20):1448-56.
27. Frueh BC, Gold PB, de Arellano MA. Symptom overreporting in combat veterans evaluated for PTSD: differentiation on the basis of compensation seeking status. J Pers Assess 1997;68(2):369-84.
28. Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, et al. Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000. J Am Soc Nephrol 2005;16(1):180-8.
29. Davies JM, Mazumder A. Health and environmental policy issues in Canada: the role of watershed management in sustaining clean drinking water quality at surface sources. J Environ Manage 2003;68(3):273-86.
30. Krewski D, Balbus J, Butler-Jones D, Haas C, Isaac-Renton J, Roberts K, et al. Managing the microbiological risks of drinking water. J Toxicol Environ Health A 2004;67(20-22):1591-617.
31. Rizak S, Cunliffe D, Sinclair M, Vulcano R, Howard J, Hrudey S, et al. Drinking water quality management: a holistic approach. Water Sci Technol 2003;47(9):31-6.
32. Blackburn BG, Craun GF, Yoder JS, Hill V, Calderon RL, Chen N, et al. Surveillance for waterborne-disease outbreaks associated with drinking water - United States, 2001-2002. MMWR Surveill Summ 2004;53(8):23-45.
33. Barron G, Buchanan S, Hase D, Mainzer H, Ransom MM, Sarisky J. New approaches to safe drinking water. J Law Med Ethics 2002;30(3 Suppl):105-8.
34. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-23.